News Archive
Roche announced today that the US Food and Drug Administration has provided 510(k) clearance for the cobas HSV 1 and 2 Test for the direct detection and differentiation of HSV-1 and HSV-2 DNA in anogenital specimens from symptomatic patients. With dual target detection and automation, the cobas HSV 1 and 2 Test provides laboratories with the capability to report up to 94 results in significantly less time than traditional methods and provides a simplified workflow for sample handling in the laboratory.
K-V Pharmaceutical Company announced today that it has entered into an agreement with U.S. Healthcare I, L.L.C. and U.S. Healthcare II, L.L.C. for a $20 million loan secured by assets of the Company. K-V will utilize the proceeds of the loan for working capital and general operating purposes.
A new Johns Hopkins Medicine study looking at medical records of more than 43,000 U.S. adults with hip-joint damaging osteoarthritis suggests that those who cannot perform daily activities independently before total hip replacement surgery are more likely to have poorer outcomes after surgery.
The Centers for Medicare & Medicaid Services (CMS) has awarded First Coast Service Options (First Coast) the A/B Medicare Administrative Contractor contract for Jurisdiction N (JN), formerly Jurisdiction 9, which includes Florida, Puerto Rico and U.S. Virgin Islands.
› Verified 7 days ago